An outside review of how UnitedHealthcare writes its medical policies gave the insurer high marks but did not look at how those policies are applied in coverage decisions.
UnitedHealth Group released the review Nov. 12. It was conducted by FTI Consulting and Rubrum Advising, a coverage advisory firm founded by a former CMS chief medical officer.
The findings matter for ASCs on two sides. UnitedHealthcare’s medical policies help set which commercial cases can move out of the hospital. UnitedHealth also owns, through Optum, SCA Health, one of the largest ASC operators in the country.
Six things to know:
1. The scope. Reviewers looked at UnitedHealthcare’s medical policy team of more than 80 people and sampled nine policies. The sample included vertebral body tethering, a spine procedure for pediatric scoliosis, along with molecular oncology testing, breast cancer imaging and durable medical equipment.
2. The verdict. All nine sampled policies met the reviewers’ criteria. The reviewers called UnitedHealthcare’s process “a strong and industry-leading approach to medical policy development, maintenance, and oversight.”
3. The gaps. Reviewers said the policies are “complex and long, making their use by doctors and members difficult.” They also flagged:
- no explicit documentation on when a new policy should be created
- no explicit documentation on how to vet clinical experts
- clinical evidence presentation that needs strengthening
- governance committee training records that need strengthening
4. What it left out. The review did not examine how policies are applied in coverage decisions. A UnitedHealth spokesperson said the review “was designed to answer a specific question” and that it was too early to say what future reviews will cover. For ASCs, a key policy is UnitedHealthcare’s outpatient surgical procedures site-of-service guideline. Under it, certain procedures done in a hospital outpatient department for most commercial members must pass a medical necessity review, with ASCs named as the alternative. An updated version takes effect Dec. 1, though UnitedHealthcare’s bulletin indicates the coverage criteria are unchanged.
5. The ASC stake. Optum bought Surgical Care Affiliates, now SCA Health, for $2.3 billion in 2017. SCA Health had more than 320 ASCs in 2025, about 5% of the U.S. market, and supports roughly 9,700 physicians. A Health Affairs study published in February by Cornell University researchers found that prices at 24 ASCs rose about 11% after Optum acquired them. The increases were concentrated in markets where Optum held a larger share of ASCs or physician practices.
6. The denial record. A KFF analysis found UnitedHealth had the highest standard prior authorization denial rate among six large Medicare Advantage insurers in 2025, at 17%. Across Medicare Advantage, 67% of appealed standard denials were overturned.
UnitedHealth CEO Stephen Hemsley said the company will use the findings to strengthen its processes.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
